The Ozempic Revolution: A Doctor's Proven Plan for Success to Help You Reverse Obesity, End Yo-Yo Dieting, and Protect Yourself from Disease

The first comprehensive user guide to GLP-1s (such as Ozempic, Wegovy, and Zepbound) with an overview of how they work and possible side effects. Also including companion recipes, exercise guidance, and new habits to maintain lifelong health and keep weight off for good.

The newest class of weight loss drugs (GLP-1s) are complete game-changers in their potential to reverse obesity and its related diseases, with nearly 50% of Americans qualifying for the use of these drugs. Already 1 in 8 Americans say they’ve tried a GLP-1 medication—but with many acquiring their prescription from online pharmacies, med spas, and general practitioners, they face a huge gap between trying the drug and achieving their health goals with it long-term.

That’s where The Ozempic Revolution comes in. Alexandra Sowa, MD, a leading obesity medicine specialist, shares her expertise on this much-discussed but largely misunderstood class of medica­tions, including information like:

• What the GLP-1 experience really feels like
• How to know if you’re a candidate for these medications
• How to get a prescription and get it covered by insurance
• How to manage and reduce unwanted side effects
• Unique food plans and strategies for managing the mental challenges of losing weight
• Simple, easy recipes for when you don’t feel like eating

Traditional and social media has been flooded with junk information and stigmatizing headlines about GLP-1s, and in this book, Dr. Sowa digs into all of it—the good, the bad, and the ugly—bringing the science to light.

If you’re curious about how GLP-1s might fit into your life, or want to optimize your experience while taking them, then Dr. Sowa’s clear-eyed, fully informed approach is a must-read. The Ozempic revolution changes everything: these drugs finally provide a viable, healthy, and sane way to lose weight, avoid disease, and maintain your health gains for life.